טוען...
Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease
OBJECTIVES: Ferumoxytol is an alternative to gadolinium-based compounds as a vascular contrast agent for magnetic resonance angiography (MRA), particularly for patients with chronic kidney disease (CKD). However, dose-related efficacy data are lacking. We aimed to determine the optimal (minimum effe...
שמור ב:
| הוצא לאור ב: | Eur Radiol |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Berlin Heidelberg
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6554242/ https://ncbi.nlm.nih.gov/pubmed/30919067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00330-019-06137-4 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|